These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31176590)

  • 41. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
    Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
    BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
    Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
    AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
    [No Abstract]   [Full Text] [Related]  

  • 44. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
    Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
    Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of lesion dimension on survival in patients with T1a renal cell carcinoma who underwent deferred surgery.
    Wang L; Huang L; Lei L; Xu Y; Huang L; Liu H; Wang H; Liu D
    Int Urol Nephrol; 2024 Sep; 56(9):2913-2921. PubMed ID: 38546805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2-4 cm: A population-based study.
    Yan S; Yang W; Zhu CM; Yan PM; Wang ZC
    Medicine (Baltimore); 2019 May; 98(21):e15610. PubMed ID: 31124938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.
    Uhlig A; Hahn O; Strauss A; Lotz J; Trojan L; Müller-Wille R; Uhlig J
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):277-283. PubMed ID: 29075878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
    Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
    J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
    Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
    Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
    Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
    J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
    Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
    World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
    Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
    J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.
    Hongo F; Yamada Y; Ueda T; Nakmura T; Naya Y; Kamoi K; Okihara K; Ichijo Y; Miki T; Yamada K; Ukimura O
    BMC Urol; 2017 Jan; 17(1):10. PubMed ID: 28100214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Factors for Long-Term Survival in Patients with Renal-Cell Carcinoma After Radiofrequency Ablation.
    Zhang F; Chang X; Liu T; Wang W; Zhao X; Ji C; Yang R; Guo H
    J Endourol; 2016 Jan; 30(1):37-42. PubMed ID: 26222920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses.
    Whitson JM; Harris CR; Meng MV
    BJU Int; 2012 Nov; 110(10):1438-43; discussion 1443. PubMed ID: 22639860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors.
    Hao G; Hao Y; Cheng Z; Zhang X; Cao F; Yu X; Han Z; Liu F; Mu M; Dou J; Li X; Dupuy DE; Yu J; Liang P
    Int J Hyperthermia; 2018; 35(1):62-70. PubMed ID: 29807450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.